|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reference Laboratory Services
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
CATEGORY/NAME OF TEST |
DESCRIPTION |
|
Antinuclear Antibody Testing |
|
|
ANA Complete Testing |
ANA screen ELISA; positives are tested by EL-ANA/8 ELISA |
|
ANA screen ELISA |
ELISA two well screening |
|
ANA ELISA Panels: levels with endpoint for each antibody |
|
ANA/7 panel |
measurement of IgG autoantibodies directed against 7 nuclear antigens: ssDNA, dsDNA (phage), Sm, RNP/Sm, SSA, SSB, and Chromatin |
ANA/9 panel |
measurement of IgG autoantibodies directed against 9 nuclear antigens: ssDNA, dsDNA (phage), Sm, RNP/Sm, SSA, SSB, Chromatin, Scl-70, and Centromere. |
Individual ELISA Antinuclear Antibody levels with endpoint |
|
Individual Antibodies |
Level of antibodies to denatured DNA (ssDNA), native bacteriophage |
Anti-cardiolipin / Anti-B2GPI Antibodies |
|
aCL screen |
Screening for anti-cardiolipin antibodies |
anti-B2GPI screen |
Screening for antibodies to B2-glycoprotein I |
aCL screen + anti-B2GPI screen |
Screening for both antibodies: aCL and B2GPI |
aCL and anti-B2GPI panels |
IgM, IgG and IgA antibodies to Cardiolipin |
aCL panel |
IgM, IgG and IgA anti-cardiolipin antibodies |
anti-B2GPI panel |
IgM, IgG and IgA antibodies to B2-glycoprotein I |
Rheumatoid Arthritis Tests |
|
Rheumatoid Factor ELISA (rabbit IgG as antigen): |
|
RF/3 |
IgM, IgG and IgA quantitative Rheumatoid Factor |
RF - IgM |
Classical quantitative Rheumatoid Factor (IU/ml) |
Anti-CCP |
|
Anti-Cyclic Citrullinated Peptide |
Antibodies to Cyclic Citrullinated Peptide |
Antineutrophil Cytoplasmic Antibodies (ANCA) |
|
Anti-Myeloperoxidase (MPO) |
Antibodies to myeloperoxidase (p-ANCA) |
| Anti-Proteinase-3 (PR3) | Antibodies to proteinase-3 (c-ANCA) |
| Vitamin D | |
| Gliadin | |
| TTG | |
| PTH | |
|
|